Ensign Peak Advisors
BHVN icon

Ensign Peak Advisors’s Biohaven BHVN Stock Holding History

Ensign Peak Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
11,388
+3,250
+40% +$35K ﹤0.01% 1452
2026
Q1 		$68.8K Hold
8,138
– – ﹤0.01% 1647
2025
Q4 		$91.9K Sell
8,138
-11,400
-58% -$141K ﹤0.01% 1591
2025
Q3 		$293K Sell
19,538
-6,900
-26% -$100K ﹤0.01% 1581
2025
Q2 		$373K Hold
26,438
– – ﹤0.01% 1623
2025
Q1 		$636K Hold
26,438
– – ﹤0.01% 1474
2024
Q4 		$987K Hold
26,438
– – ﹤0.01% 1329
2024
Q3 		$1.32M Buy
26,438
+3,300
+14% +$128K ﹤0.01% 1158
2024
Q2 		$803K Buy
23,138
+100
+0.4% +$3.95K ﹤0.01% 1419
2024
Q1 		$1.26M Sell
23,038
-139,501
-86% -$6.91M ﹤0.01% 1171
2023
Q4 		$6.96M Buy
162,539
+88,668
+120% +$2.76M 0.01% 542
2023
Q3 		$1.92M Buy
73,871
+2,858
+4% +$59.4K ﹤0.01% 850
2023
Q2 		$1.7M Buy
71,013
+19,650
+38% +$338K ﹤0.01% 939
2023
Q1 		$702K Hold
51,363
– – ﹤0.01% 1511
2022
Q4 		$713K Buy
+51,363
New +$725K ﹤0.01% 1439

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ensign Peak Advisors's BHVN Position: Q2 2026 in Review

Ensign Peak Advisors increased its Biohaven (BHVN) stake by 40% in Q2 2026, buying an estimated $35K and bringing the position to 11,388 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1452.

Ensign Peak Advisors first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.96M in Q4 2023. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Ensign Peak Advisors held 11,388 shares of Biohaven worth $169K as of Q2 2026.
  • Ensign Peak Advisors bought 3,250 Biohaven shares in Q2 2026, an estimated $35K.
  • Biohaven made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1452 holding.
  • Ensign Peak Advisors first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Ensign Peak Advisors's Biohaven position peaked at $6.96M in Q4 2023.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.